DNER and Thrombocytopenia: According to current studies, nausea/vomiting, thrombocytopenia, fatigue, diarrhea, dysgeusia, anemia, decreased appetite, and hyperglycemia are the most common adverse effects of BET inhibitors.117,120,126,163,165,178–180 Most of these adverse effects also occur with other anticancer drugs and are tolerated by patients; however, some can have serious consequences and must be treated with caution.